0001209191-22-010239.txt : 20220216
0001209191-22-010239.hdr.sgml : 20220216
20220216172219
ACCESSION NUMBER: 0001209191-22-010239
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220214
FILED AS OF DATE: 20220216
DATE AS OF CHANGE: 20220216
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Richardson Charles E
CENTRAL INDEX KEY: 0001875096
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40655
FILM NUMBER: 22644707
MAIL ADDRESS:
STREET 1: 1616 EASTLAKE AVENUE E.
STREET 2: SUITE 208
CITY: SEATTLE
STATE: WA
ZIP: 98102
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Icosavax, Inc.
CENTRAL INDEX KEY: 0001786255
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1616 EASTLAKE AVE E, SUITE 208
CITY: SEATTLE
STATE: WA
ZIP: 98102
BUSINESS PHONE: (206) 737-0085
MAIL ADDRESS:
STREET 1: 1616 EASTLAKE AVE E, SUITE 208
CITY: SEATTLE
STATE: WA
ZIP: 98102
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-02-14
0
0001786255
Icosavax, Inc.
ICVX
0001875096
Richardson Charles E
C/O ICOSAVAX, INC.
1616 EASTLAKE AVENUE E., SUITE 208
SEATTLE
WA
98102-3793
0
1
0
0
SVP, Technical Operations
Common Stock
2022-02-14
4
M
0
66375
0.84
A
161200
D
Common Stock
2022-02-14
4
M
0
6186
1.04
A
167386
D
Stock Option (Right to Buy)
0.84
2022-02-14
4
M
0
66375
0.00
D
2029-09-12
Common Stock
66375
43489
D
Stock Option (Right to Buy)
1.04
2022-02-14
4
M
0
6186
0.00
D
2031-01-28
Common Stock
6186
16657
D
25% of the shares subject to the option vested on 9/13/2020, and 1/48th of the shares subject to the option vest monthly thereafter.
25% of the shares subject to the option vested on 1/29/2022, and 1/48th of the shares subject to the option vest monthly thereafter.
s/ Elizabeth Bekiroglu, Attorney-in-Fact for Charles E. Richardson
2022-02-16